Menopause, estrogens and frailty
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The controversy surrounding the results from the Women's Health Initiative (WHI) trials published a decade ago caused a significant decline in the use of menopausal hormone replacement therapy. However, these results have been vehemently contested and several lines of evidence suggest that in perimenopausal and non-obese women, estrogen therapy may indeed be of benefit. There is ample proof that menopause causes a loss of musculoskeletal tissue mass and quality, thereby causing a loss of health and quality of life. There is also solid evidence that hormone replacement therapy in itself prevents most of these effects in connective tissue in itself. Besides the independent, direct effects on the musculoskeletal tissues, estrogen deficiency also reduces the ability to adequately respond and adapt to external mechanical and metabolic stressors, e.g. exercise, which are otherwise the main stimuli that should maintain musculoskeletal integrity and metabolic function. Thus, normophysiological estrogen levels appear to exert a permissive effect on musculoskeletal adaptations to loading, thereby likely improving the outcome of rehabilitation following critical illness, musculoskeletal trauma or orthopedic surgical therapy. These effects add to the evidence supporting the use of estrogen therapy, particularly accelerated gain of functional capacity and independence following musculoskeletal disuse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., Ko, M., LaCroix, A. Z., Margolis, K. L., & Stefanick, M. L. (2007) · JAMA · doi:10.1001/jama.297.13.1465 · Cited by 1,741 · cited 1×
“The extent of primary effects as well as adverse depend strongly on weight [11,14], time since onset of menopause [15,16], smoking behavior [14] and glucocorticoid treatment [17–19].”
BackgroundEstrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in Osteoclasts
Nakamura, T., Imai, Y., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi, K., Harada, Y., Azuma, Y., Krust, A., Yamamoto, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.025 · Cited by 1,013
Khosla, S., Oursler, M. J., & Monroe, D. G. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.03.008 · Cited by 943
Salpeter, S. R., Walsh, J. M. E., Ormiston, T. M., Greyber, E., Buckley, N. S., & Salpeter, E. E. (2006) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00545.x · Cited by 640
The Influence of Estrogen on Skeletal Muscle: Sex Matters
Enns, D. L., & Tiidus, P. M. (2010) · Sports Medicine · doi:10.2165/11319760-000000000-00000 · Cited by 374
Sex differences in exercise metabolism and the role of 17-beta estradiol.
TARNOPOLSKY, M. A. (2008) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31816212ff · Cited by 354
Moran, A. L., Nelson, S. A., Landisch, R. M., Warren, G. L., & Lowe, D. A. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01305.2006 · Cited by 208 · cited 1×
“Third, estrogen status has been shown to be related to myosin binding capability and thus affect actomyosin mechanokinetics in skeletal muscle [54,57].”
BackgroundRonkainen, P. H. A., Kovanen, V., Alén, M., Pöllänen, E., Palonen, E.-M., Ankarberg-Lindgren, C., Hämäläinen, E., Turpeinen, U., Kujala, U. M., Puolakka, J., et al. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91518.2008 · Cited by 168
Selective estrogen receptor-β activation stimulates skeletal muscle growth and regeneration
Velders, M., Schleipen, B., Fritzemeier, K. H., Zierau, O., & Diel, P. (2012) · The FASEB Journal · doi:10.1096/fj.11-194779 · Cited by 162
Moran, A. L., Warren, G. L., & Lowe, D. A. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01029.2005 · Cited by 123 · cited 2×
“for regrowth of muscle, a finding of potentially grave importance in a human clinical context [9,54].”
Background
Cited by
The 2017 hormone therapy position statement of The North American Menopause Society
(2017) · Menopause · doi:10.1097/gme.0000000000000921 · Cited by 1,001
The 2022 hormone therapy position statement of The North American Menopause Society
(2022) · Menopause · doi:10.1097/gme.0000000000002028 · Cited by 977
Metadata
- Authors
- Nedergaard, A., Henriksen, K., Karsdal, M. A., & Christiansen, C.
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2013-02-06
- Volume
- 29
- Issue
- 5
- Pages
- 418-423
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W2081052253
- Cited by
- 56
- References
- 13
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Menopause, estrogens and frailty. https://app.cochat.ai/papers/10.3109/09513590.2012.754879
- The paper
- Nedergaard, A., Henriksen, K., Karsdal, M. A., & Christiansen, C. (2013). Menopause, estrogens and frailty. Gynecological Endocrinology. https://doi.org/10.3109/09513590.2012.754879
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.